As the peripheral sympathoadrenal axis is tightly controlled by the cortex via hypothalamus and brain stem, the central pathological features of Hunting's disease, (HD) that is, deposition of mutated huntingtin and synaptic dysfunctions, could also be expressed in adrenal chromaffin cells. To test this hypothesis we here present a thorough investigation on the pathological and functional changes undergone by chromaffin cells (CCs) from 2-month (2 m) to 7-month (7 m) aged wild-type (WT) and R6/1 mouse model of Huntington's disease (HD), stimulated with acetylcholine (ACh) or high [
Huntington's disease (HD) is a neurodegenerative autosomal dominant disorder involving hyperkynetic involuntary movements, progressive dementia, aggressiveness, and paranoid psychosis. The HD gene codes for the protein huntingtin that when mutated, exhibits an expansion in the number of cytosine, adenine, guanine (CAG) trinucleotide repeats in the exon 1 of the gene (MacDonald et al. 1993) . Anomalous expansion of CAG repeats gives rise to misfolded huntingtin that accumulates in the cytoplasm and nucleus to form aggregates. This associates with neuronal loss in the caudate nucleus and putamen, in cortical layers III, IV, and VI as well as in the lateral tuberal nucleus of the hypothalamus (Kremer et al. 1990; Vonsattel and DiFiglia 1998) . Thus, neuronal death in those brain regions and the formation of intranuclear and cytoplasmic aggregates containing the mutant huntingtin with and extended polyglutamine stretch, are the two important markers of human HD that have been mimicked in mouse models.
The R6/1 and R6/2 transgenic mice were first developed to study HD. They both express exon 1 of the human HD gene with around 115 and 150 CAG repeats, respectively (Mangiarini et al. 1996) . Out of several other mouse models of HD, the R6/2 is the one that develops symptoms the most rapidly and has the most widespread occurrence of huntingtin inclusions in the brain (Li et al. 1995) . However, R6/1 mouse models of HD have also been used in our and other laboratories because they reproduce several features of human HD, although at elder ages Li et al. 2005; Rubio et al. 2009a; Rozas et al. 2011) .
Synaptic dysfunction (Li et al. 2003) and altered neurotransmitter release in R6 mice, have been reported (Lievens et al. 2001; Nicniocaill et al. 2001; Behrens et al. 2002; Petersen et al. 2002) . Also, electrically evoked dopamine release is attenuated in brain slices from 6-week-old R6/2 mice (Johnson et al. 2006 ) and 12-week-old R6/2 mice (Johnson et al. 2007 ) that showed the overt phenotype, compared with age-matched wild-type (WT) littermates. A diminished exocytotic release of acetylcholine (ACh) (Vetter et al. 2003) , glutamate (Li et al. 2003) , and insulin (Bj€ orkqvist et al. 2005) also occurs in R6/2 mouse models of HD. Opposite data have also been reported, that is, at the neuromuscular junction of 5-6-month-old R6/1 mice, with increased evoked neurotransmitter release (Rozas et al. 2011) .
A previous study analyzed the quantal release of catecholamines in chromaffin cells (CCs) from the fast-developing HD mouse model R6/2 at 3 months of age; authors found that K + stimulation triggered a response with similar secretory spike number (SN) but lower catecholamine content per vesicle (Johnson et al. 2007 ). However, in that early study those exocytotic parameters were not monitored at an early pre-disease stage. Neither, these authors studied the possible alterations of the kinetics of exocytosis, the kinetics of the fusion pore, cell excitability, ion currents, the tissue levels of adrenal medulla dopamine beta-hydroxylase (DBH) and catecholamines, or the expression of mutated huntingtin in CCs. Thus, in this frame, we planned this investigation to explore those parameters in the slow-developing HD R6/1 mouse model at 2 months of age (absence of motor symptoms, pre-disease stage, 2 m) and at 7 months of age (motor deficits present, disease stage, 7 m), in comparison with WT mice of matched ages. We have found profound alterations of those parameters in 7 m R6/1 mice with respect 7 m WT mice. Of interest was that several of those alterations were already present at a pre-disease stage. This study add evidence on alterations of CC excitability and exocytosis in mouse models of neurodegenerative diseases such as Alzheimer's disease (AD) APP/PS1 (de Diego et al. 2012) as well as amyotrophic lateral sclerosis (ALS) SOD1
G93A (CalvoGallardo et al. 2015) .
Materials and methods

Animals and procedures
Ethics statement
All procedures used in this work were in accordance with the European Union Council Directive (86/609/EEC). The protocol was approved by the Committee on the Ethics of Animal Experiments of the Hospital 'Ramon y Cajal' (animal facilities ES280790002001). Huntington's disease (HD) R6/1 transgenic (Tg) mice generated by Professor Gillian Bates (Mangiarini et al. 1996) , were obtained from Jackson Laboratory (Bar Harbor, ME, USA) and generously donated by Professor J.J Lucas (Center of Molecular Biology 'Severo Ochoa,' Autonomous University of Madrid). The wild-type mice (WT) and R6/1 transgenic mice were obtained from R6/1 male (CBA/C57BL6 background) (Cat# JAX:006471, RRID: IMSR_JAX:006471) and wild-type (B6CBAF1/OlaHsd background) (Cat#6552451, RRID:MGI:5652451) female mice intercross. They were housed in a pathogen-free facility in a temperaturecontrolled room (20-24°C) with a 12 h light/dark cycle and with food and water ad libitum. The total numbers of mice used in this study were 16 WT and 16 R6/1 (age 2 m) and 18 WT and 18 R6/1 (age 7 m). No sample calculation was performed to estimate the number of mice used in each experimental group. No randomization was performed to allocate subjects in the study. Additionally, no blinding was performed. Furthermore, we used the minimum number of mice in the search of a threshold for statistical significant differences between data from WT and R6/1 mice. Also, there were no sample size variations at the beginning and end of the experiments.
Transgenic mice
The N-terminal transgenic mouse R6/1 (B6.Cg-Tg(HDexon1) 61Gpb/J Mus Musculus (Cat# JAX:006471, RRID:IMSR_ JAX:006471) was the first genetic mouse model of HD generated in 1996 (Mangiarini et al. 1996) by transgenesis of a small fragment of the 5 0 end of the human huntingtin (HTT) gene, into the mouse genome. The fragment inserted is composed of $ 1 kb of 5 0 UTR sequences, exon 1 carrying expanded CAG repeats of $ 130 units and the first 262 bp of intron 1. The transgenic mice were engineered via pronuclear injection and the transgene is integrated in a random fashion and expressed under the control of the human htt promoter. The R6/1 transgenic mouse here used expresses mutant exon 1 of the truncated human HD gene with approximately 115 CAG repeats, which lead to production of a short fragment of huntingtin with an abnormally long polyglutamine tract at the N-terminal portion of the protein (Mangiarini et al. 1996) . The R6/1 mouse model of HD displays a slow but robust disease progression and dies approximately at month 9 for unknown reasons. This transgenic mouse develops HD-like symptoms, exhibiting body weight loss as well as deficits in motor coordination, locomotor activity, and cognitive function starting at 3-5 months of age. In previous work using R6/1 mouse, we observed the first signs of impairment in motor activity at 4 months of age, when mice reduced the length of the hind limb stride and the motor coordination, analyzed as time spent in the Rota-Rod (Rubio et al. 2009 ). Global motor activity measured as the total distance run using a photoelectric actimeter (Actitrack LE 8811; PanLab S.L. Barcelona, Spain), was also reduced in R6/1 mice after 6 months of age. The HD pathology also includes nigrostriatal system dysfunction in R6/1 mice with a marked agedependent reduction in dopamine neurons of SN and striatal dopamine and c-AMP-regulated phosphoprotein (DARPP-32) neurons (a marker of medium size and small efferent spiny striatal neurons), which are critical for dopamine dependent striatal synaptic plasticity. Furthermore, at 7 months of age dopamine, 3,4-dihydroxiphenylacetic acid (DOPAC), and homovanillic acid (HVA) levels are significantly decreased in striatum of R6/1 mice compared with control mice. The accumulation of huntingtin in form of nuclear inclusions appeared in young mice at the age of 1 month, before neurological symptoms appeared, and increased progressively with age. These nuclear aggregates were also present in post-mitotic cells of a number of non-neuronal tissues including adrenal gland, liver, pancreas, heart, dermis, and muscle, but its effects on HD pathology are largely unknown (Sathasivam et al. 1999; Josefsen et al. 2008; Moffitt et al. 2009 ).
Genotype determination
Genomic DNA was extracted from mouse tail after proteinase K digestion (16 h at 55°C) in lysis buffer according to the manufacturer's instructions (Highly Pure PCR template preparation kit, Roche, Barcelona, Spain). For genotyping R6/1 mice 150 ng of genomic DNA were denatured for 3 min at 94°C and subjected to 35 cycles of 1 min at 94°C, 1 min at 55°C, and 1 min at 72°C, followed by 5 min of a final extension at 72°C. PCR was performed in a final volume of 25 lL containing 0.75 U of Taq DNA polymerase (Promega, Madrid, Spain; 5 U/mL), 0.2 mM dNTP, 1.5 mM MgCl 2 , 5 mM TrisHCl (pH 8.0), 0.5 lL of dimethylsulfoxide and 1.5 lL of specific sense and antisense primers at 10 lM. The specific primers were as follows: HD-1D: 5 0 -CCGCTCAGGTTCTGCTGCTTTT A-3 0 , and HD-1R: 5 0 -TGGAAGGACTTGAGGGACTC-3 0 . 20 lL of the PCR reaction products were analyzed by electrophoresis in a 1.8% agarose gel that was subsequently stained with GelStarH from Cambrex (Bio Science Rockland, Inc.) for visualization of DNA bands. DNA molecular weight markers (Roche, Spain) were used to provide a size reference for the test reactions. The sizes of PCR products are used for the identification of the genotype, 170 bp for mutant huntingtin.
Exploration of motor function
WT mice and R6/1 mice were included at ages of 2 and 7 months; mice younger than 2 months age or older than 7 months age were exluded.
Footprint test
The footprint test was used to compare the gait of R6/1 mice with that of WT mice. To obtain footprints, the hind feet of the mice were coated with non-toxic blue paint. The animals were then allowed to walk freely along a 60-cm-long, 10-cm-wide runway white paper sheet (with 20-cm-high walls) into an enclosed box. Before starting the test, all mice had three training runs and a fresh sheet of white paper was placed on the floor of the runway for each run. To analyze the distance travelled during 10 min by an animal in an open field, we used a photoelectric monitor of motor activity (Actitrack) Panlab, Barcelona, Spain). This apparatus consists of a transparent platform (22.5 9 22.5 cm) equipped with photoelectric cells. The locomotor activity is then analyzed with appropriate software. Stride length (mm) was measured as the average distance of forward movement between each stride. After three training runs until animal run to the end of the paper sheet, one trial was analyzed per mouse and a minimum of five strides were tabulated, excluding starting and stopping steps. For testing the hind paws in this test animals were painted with non-toxic paint. No animal had to be excluded.
Rota-rod test
Motor coordination was evaluated in the Rota-Rod (Panlab, Barcelona, Spain). We performed a 1-day and one session accelerated rota-rod test on R6/1 and WT littermates. The mice are placed on a rod in movement, and after two tests of adaptation at constant speed and a rest period, the mice performed three trials on the rod with a maximum time of 3 min at an initial speed of 4 rpm and accelerate gradually on 30 s to a maximum of 40 rpm. The animals unable to walk on the rod for at least 60 s were excluded and replaced by others. In our experimental groups all animals exceeded 60 s of permanence in the rota-rod and no animal had to be excluded. The time spent on the rod is recorded automatically for each animal, and the average performance in the three consecutive trials is used for within-animal comparisons. Notably, for rota-rod and footprint studies, a separate cohort of mice was used for each experimental group.
Adrenal processing for neurochemical, histology, and immunohistochemistry assays
In the present work we used 'pre-symptomatic' 2-month-old and 'symptomatic' 7-month-old R6/1 female mice. Briefly, a total of 39 females were divided into the following four groups: 2-month-old WT group (n = 8); 2-month-old R6/1 group (n = 6), 7-month-old WT group (n = 10) and 7-month-old R6/1 group (n = 15).). The precise numbers of animals used are given in the respective figure legend. Animals were killed by cervical dislocation and glands were prepared for HPLC analysis of catecholamines and immunostaining (see later). The left glands were rapidly dissected on ice and stored at À80°C until catecholamine concentrations were measured via electrochemical detection. The right glands were immersed in 4% paraformaldehyde for 24 h before being processed and paraffin embedded for huntingtin immunohistochemical analysis.
Determination of catecholamines
Adrenal medulla adrenaline (A), noradrenaline (NA), and dopamine (DA) were measured by HPLC with an ESA coulochem detector. Briefly, the left adrenal glands were sonicated in 150 lL of 0.4 N perchloric acid and then centrifuged at 10 000 g at 4°C for 20 min; the supernatant was used for HPLC analysis, and the pellet was analyzed for protein content by using the BCA Protein Assay Kit (Pierce, Rockford, IL, USA). Monoamine levels were determined from 20 lL of the resulting supernatant. The chromatographic conditions were as follows: a column (Nucleosil 5C18); the mobile phase, a citrate/acetate buffer 0.1 M, pH 3.9 with 10% methanol, 1 mM EDTA, and 1.2 mM heptane sulfonic acid; and the detector voltage conditions: D1 (+0.05 V), D2 (À0.39 V), and the guard cell (+0.40 V), have been described previously (Mena et al. 1994) .
Histology and immunohistochemistry
For histology and immunohistochemistry assays, the adrenal glands were immersed in paraformaldehyde for 24 h, dehydrated in a graded series of ethanol, embedded in paraffin, and sectioned at a thickness of 4 lm. Two different sections by gland were stained with hematoxylin/eosin (H&E) for tissue identification and immunoperoxidase stained with HTT antibody (Chemicon, Madrid Spain; Cat# MAB5374, RRID: AB_177645). Sections were rehydrated, incubated in 4% hydrogen peroxide for 10 min, washed in 0.1 M Tris-HCl pH 7.5, 0.9% NaCl (TBS) and sequentially blocked with UltraVision protein block for additional 1 h. Sections were incubated at room temperature for 1 h with mouse anti-HTT monoclonal antibody MAB5374 diluted 1 : 100 and then washed in TBS. Subsequently, the sections were incubated with primary antibody amplifier quanto [M aster Diagn ostica (MD), Granada, Spain] for 10 min. After rinsing with TBS, the sections were incubated with horseradish peroxidase (HRP) Polymer Quanto for 10 min and washed three times with TBS. Mutated huntingtin (mHtt) nuclear inclusions were visualized by addition of Diaminobenzidine (DAB) Quanto Chromogen: Substrate for 3 min. Tissues were counter-stained with hematoxylin. Negative controls were tested by incubation without the primary antibody.
Immunohistofluorescence for DBH For dopamine beta-hydroxylase (DBH) immunohistofluorescence, gland sections were rinsed in phosphate-buffered saline (PBS), treated with 2% H 2 O 2 in methanol for 15 min, rinsed in PBS-0.5% Triton X-100, blocked with 10% of normal goat serum in PBS-0.5% Triton X-100 and incubated overnight at 4°C with polyclonal rabbit antibody against DBH (TA308366; OriGene Technologies, Inc., Rockville, USA) diluted 1:200. After rinsing in PBS-0.5% Triton X-100, sections were incubated 90 min with Alexa 
Counting of huntingtin positive cells
To quantify positively huntingtin immunostained cells, two consecutive adrenal gland sections per animal and five animals per age and genotype were examined. The total number of cells expressing huntingtin nuclear aggregates was scored in 6 fields by section, using a Nikon Eclipse E400 optic microscope under 409 magnification. The cells with huntingtin aggregates were counted in the adrenal medulla manually and were expressed as the percentage of total cells counted (a minimum of 100 cells for field were counted).
Primary cultures of mouse chromaffin cells Male mice were killed by cervical dislocation. Both adrenal glands from a mouse were rapidly collected and placed in ice-cold Locke solution of the following composition (in mM): 154 NaCl, 5.5 KCl, 3.6 NaHCO3, 10 Hepes, and 5.5 glucose (pH 7.4, NaOH). Glands were fat-trimmed and medullae were isolated by removing the cortex. Next, medullae were placed in a tube containing 200 lL of Locke's solution with papain (25 U mL-1, Sigma-Aldrich, Madrid, Spain) for tissue digestion during 28 min at 37°C. This solution was exchanged for 1 mL Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich), repeating the exchange three times and leaving finally 100 lL of DMEM. Then medullae were minced with a 1 mL micropipette, and DMEM was placed in a separate tube. The remaining medullae were minced again with a 200 lL micropipette in 80 lL of new DMEM. Finally, the remaining medullae were extracted and both the 100 lL and the 80 lL DMEM containing cells were put together. About 10-20 lL drops of cell-containing DMEM were placed on poly-D-lysine-coated coverslips of 24-wells plates. After 45 min in the incubator (37°C, water saturated, 5% CO 2 atmosphere), 700 lL DMEM supplemented with 4% fetal bovine serum, 50 IU/ mL penicillin and 50 lg/mL streptomycin were added to each well and remained in the incubator for 1-2 days during which the experiments were done.
Measurements of membrane potential, action potential, and ion currents
Coverslips containing the cells were placed on a chamber mounted on the stage of a Nikon Diaphot inverted microscope. Cells were continuosly superfused with a Krebs-HEPES solution composed of (in mM): 145 NaCl, 5.6 KCl, 1.2 MgCl 2 , 2 CaCl 2 , 11 glucose, and 10 HEPES (pH 7.4, NaOH).
Recording of membrane potential (V m ) and action potentials (APs) were made using the current-clamp mode in the whole-cell configuration of the patch-clamp technique (Hamill et al. 1981) . The intracellular pipette solution had the following composition (in mM): 120 K-glutamic acid, 14 EGTA, 10 NaCl, 5 Mg-ATP, 0.3 Na-GTP, and 20 HEPES (pH 7.3, KOH).
Inward and outward whole-cell currents were recorded using the voltage-clamp configuration of the patch-clamp technique (Hamill et al. 1981) . For the recording of sodium currents (I Na ), calcium currents (I Ca ), and currents through nicotinic receptors for acetylcholine (I ACh ), cells were internally dialyzed with a pipette solution containing (in mM): 100 Cs-glutamate, 14 EGTA, 20 TEA-Cl, 10 NaCl, 5 Mg-ATP, 0.3 Na-GTP, and 20 HEPES (pH 7.3, CsOH). For the recording of the two main components of outward potassium currents (I K ), namely the voltage-dependent component (I K(v) ) and the calcium-dependent component (I K(Ca) ), the pipette solution had the following composition (in mM): 120 K-glutamic acid, 14 EGTA, 10 NaCl, 5 Mg-ATP, 0.3 Na-GTP, and 20 HEPES (pH 7.3, KOH). Once the membrane patch ruptured, the cell being explored was rapidly, continuously, and locally perifused by gravity with Krebs-HEPES solution, at a flow rate of 1 mL/min at room temperature (24 AE 2 ⁰C). For I Na and I K(v) recordings the external solution contained 0 nominal Ca 2+ and for other currents the external solution contained 2 mM Ca 2+ . External solutions were rapidly exchanged (within less than a second) by using electronically driven miniature solenoid valves coupled to a multibarrel concentration-clamp device, its common outlet being placed within 100 lm of the cell.
Whole-cell recordings were made with fire-polished borosilicate pipettes with resistance 3-6 MΩ, mounted on the headstage of an EPC-9 patch-clamp amplifier (HEKA Elektronik, Lambrecht, Germany), allowing cancellation of capacitative transients and compensation of series resistance. Data were acquired with a sample frequency of 20 kHz by using Pulse v8.74 software (HEKA Elektronik). To measure the different currents, cells were held at À80 mV. I Na was generated by 10-ms depolarizing pulses (DPs) from À60 to +60 mV every 15 s with 10 mV steps; I Ca by 50-ms DPs from À60 to +70 mV every 10 s with 10 mV steps; and I ACh by the fast application for 250 ms of a solution containing 100 lM ACh. Finally, I K was generated by the application of a 400 ms DPs from À40 mV to +150 mV every 20 s with 10 mV steps. Current-clamp experiments were analyzed using Clampfit software (Molecular Devices, CA, USA) and voltage-clamp experiments with Pulse v8.74 software (HEKA Electronik, Lambrecht, Germany).
Measurement of cytosolic calcium transients
To measure [Ca 2+ ] c transients in CCs stimulated with ACh or K + , cells plated on overslips were incubated for 1 h at 37°C in DMEM medium containing the calcium probe fura-2 acetoxymethyl ester (fura-2 AM, 10 lM). Thereafter, coverslips were mounted in a chamber and cells were washed and covered with Tyrode solution. The setup for microfluorescence monitoring consisted in a Leica DMI 4000B inverted light microscope (Leica Microsystems, Barcelona, Spain) equipped with an oil immersion objective (Leica 409 Plan Apo, numerical aperture 1.25). Then, cells were continuously superfused by means of a five-way system with a common outlet 0.28-mm tube driven by electrically controlled valves, with Tyrode solution at room temperature (37°C) and 1 mL/min. Fura-2 was alternatively excited at 340 AE 10 and 380 AE 10 nm, using a K€ uber CODIX xenom arc lamp (Leica). Emitted fluorescence was measured at 540 AE 20 nm and quantified with an intensified charge-coupled device camera (Hamamatsu camera controller C10600 ORCA R 2 ). Fluorescence images were generated at 1-s intervals.
Monitoring of the quantal release of catecholamines
Carbon fiber microelectrodes were built as previously described (Wightman et al. 1991) by introducing a 10-lm diameter graphite fiber (Amoco, now part of BP-Group, London, UK) into glass capillary tubes (Kimble-Kontes, Vineland, NJ, USA). These tubes were then pulled (Narishige PC-10 pipette puller; Narishige, Tokyo, Japan), and the carbon fiber was inserted in both thin ends of the pulled tube and was cut with a pair of small scissors obtaining thus two pipettes with a carbon fiber piece sticking out of each tip. The tip was sealed by a two-component epoxy (EPIKOTE 828-Miller-Stephenson, Danbury, CT, USA) and m-phenylendiamine, 14% (Aldrich, Steimheim, Germany). The electrodes were left overnight to dry, introduced into an oven at 100°C for 2 h, and then kept another 2 h at 150°C. The amperometer was made at Segainvest, a company of Universidad Aut onoma de Madrid, Spain. It was connected to an interface (PowerLab/4SP; ADInstruments, Oxford, UK) that digitized the signal at 10 KHz, sending it to a personal computer that displayed it within the Pulse 8.74 software (HEKA Elektronik). A 700 mV potential was applied to the electrode with respect to an AgCl ground electrode. The electrodes were calibrated by superfusing 50 lM noradrenaline dissolved in Tyrode; only electrodes that yielded a current between 200 and 400 pA were used (Machado et al. 2008) .
The coverslips with the attached CCs were mounted in a chamber on a Nikon Diaphot inverted microscope used to localize the target cell, which was locally, rapidly, and continuously superfused by means of a five-way superfusion system with a common outlet driven by electrically controlled valves, with Tyrode solution at 37°C. Cells were stimulated either with ACh (100 lM, 1 min) or high K + (70 mM K + for 1 min prepared by replacing equiosmolar concentrations of NaCl with KCl). The ACh solution was prepared by dissolving the proper amount of stock solution into Tyrode.
Data acquisition and their statistical analysis
Test for outliers (i.e., Grubs's test or ESD Methods) were not applied Statistical significance in Figs 1-3, was assessed using Student 0 s t-test for comparison of two groups, one-way ANOVA with post-hoc Tukey 0 s correction for the comparison of one variable between more than two groups, and two-way ANOVA with post-hoc Bonferroni correction for the comparison of two variables between groups. We detect that the data fitting normal distribution using Kolmorov test with DallalWilkinson-Lillierfor P value. All analyses were performed using GraphPad Prism 6.01 software package (San Diego, CA ).
Data of Figs 4-8 and Tables 1-4 were analyzed with different statistical tests. In each case, the normality of data was previously tested in order to apply the adequate test in each case. The test chosen in each case is next described and is also mentioned in figure legends.
Data on cell excitability, ion currents, and Vm were first subjected to normality test (D'Agostino and Pearson Omnibus Normality test) and we found that some parameters followed a normal distribution and others no. Thus, we applied a Mann-Whitney test in all cases.
Data from measurement of [Ca 2+ ] c were expressed as ratios of excitation wavelengths (340/380 nm). Graphs and the mathematical analyses were performed using the GraphPad Prism Software version 5.01 (GraphPad Software). Statistical analyses were carried out with the Mann-Whitney test.
The secretory amperometric records were analyzed on a personal computer using excel software (Microsoft, Redmond, WA, USA) and IgorPro software (Wavemetrics, Lake Oswego, OR, USA). The kinetic analysis of single amperometric events (spikes) was performed as previously described (Fern andez-Morales et al. 2009) using a macro written in IgorPro Software (Mosharov and Sulzer 2005) . Mean values for all the spikes of each cell were obtained and then pooled together for statistical comparison; this method helps overcoming the large variability in spike number and spike kinetics by giving each cell the same weight independently of the number of spikes produced. Data on quantal secretion Fig. 8 , Tables 3 and 4 were analyzed by using the Mann-Whitney test. Median values for all the spikes of each cell were obtained and then pooled together for statistical comparison; this method helps overcoming the large variability in spike number and spike kinetics by giving each cell the same weight independently of the number of spikes produced. Differences between means of group data with non-normal distribution (we detect that the data not fitting normal distribution with D'Agostino and Pearson test) were assessed using Mann-Whitney test to compare two groups (WT vs R6/1 mice).
In all cases *p < 0.05 was taken as the limit of statistical significance, and **p < 0.01 and ***p < 0.001 were taken as higher levels of statistical significance.
Materials and chemicals
All reagents were obtained from the following sources and catalog numbers: 
Results
All parameters next described were monitored in parallel in WT and R6/1 mice at pre-symptomatic disease stages integral optical density (IOD). Data are expressed as means AE SEM (n = 6-8 animals in each experimental group). Statistical analysis was performed by one or two-way ANOVA followed by Tukey's multiple comparison test and Bonferroni post-test, respectively. *p < 0.05, **p < 0.01, ***p < 0.001 as compared with the same genotype at different age; +++ p < 0.001, as compared R6/1 with the corresponding WT at the same age. There is interaction between age and genotype effects on body weight F(1,20) = 74.43 with a p < 0.0001, on gland weight F(1,15) = 10.24 with a p = 0.0060, on NA levels F(1,31) = 5.69 with a p = 0.0234 and for AD levels (1,31) = 37,28 with a p < 0.0001.
(2 months of age, 2 m) or in mice with already established motor dysfunction (7 months of age, 7 m).
Motor function
Changes in the length of the hind limb stride were used as an index of basal ganglia dysfunction. As shown in Fig. 1a , no significant difference between R6/1 and WT mice was observed for stride lengths at 2 m. One-way ANOVA revealed that 7 m transgenic R6/1 mice made significantly shorter steps with hindlimbs (p < 0.0001) than WT littermates and R6/1 at 2 m. WT mice between 2 m and 7 m increased the stride length possibly because of the increase in their weight and size (p = 0.0099).
As shown in Fig. 1b , R6/1 and WT 2 m mice displayed a similar walking behavior on the rota-rod, whereas 7 m R6/1 mice fell from the rota-rod significantly earlier, at lower rotating speed than WT mice littermates (p < 0.0001).
Body weight
Wild-type as well as R6/1 mice developed normally and gained weight until 2 m age (Fig. 2a) . From this time onwards, WT mice continued gaining weight while R6/1 mice lost about 10% weight. Thus at 7 m, the weight of WT mice almost doubled that of R6/1 mice (Fig. 2a) .
Adrenal gland weight and protein expression There were no significant differences between the weight of WT and R6/1 glands at 2 m. Left adrenal glands from WT mice weighed an average of 2.7 mg at 2 m, and this increased significantly with age, reaching 4.2 mg at 7 m. In contrast to WT, the weight of the R6/1 mouse glands remained constant from 2 to 7 months with an average weight of 2.1 to 2.3 mg, respectively (Fig. 2b) . When we analyzed the amount of total protein expressed, the data showed a significant decrease at 7 months of age in the R6/1-gland mice with respect to the protein values in the WT-glands (data not shown).
Changes of catecholamine content and dopamine b-hydroxilase expression in adrenal medullary tissue The gland levels of catecholamines for WT and HD mice are presented in Fig. 2 . Noradrenaline (NA) and adrenaline (A) levels were significantly higher in WT than in HD mice at both ages; DA levels were increased significantly only at 7 m. In WT mice, the levels of NA and A were maintained and even were significantly increased for DA from 7 months of age, whereas in HD mice the content of NA and A decreased significantly and DA levels remained at the same level as that measured at 2 months (Fig. 2c-e) .
The adrenal medullary tissue content of DBH was determined with immunocytochemistry and its quantification was done with integral optical density. Figure 2f shows photomicrographs of DBH staining with a specific antibody and Fig. 2g shows the quantification by integral optical density of DBH expression. At 2m, DBH expression was similar in WT and R6/1 glands; however, at 7 m DBH expression in R6/1 tissue was decreased by 65% with respect WT. This result is consistent with the decrease in NA and AD content shown in glands of R6/1 mice compared with 7 m WT mice (Fig. 2c,d ).
Inclusion pathology in adrenal glands of R6/1 mice Nuclear inclusions were found throughout the adrenal gland namely, in the capsule, cortex and medulla of 7 m R6/1 mice and were absent from nuclei of WT mice. Inclusions were especially abundant in the medulla, rather scarce in the cortex and occasional in the capsule of 7 m R6/1 mice. At this symptomatic age, nuclear inclusions were detected in 66% of CCs (Fig. 3d) . Staining of the cellular nucleus consisted of 1 round inclusion strongly positive for huntingtin protein ( Fig. 3a and b) . The adrenal medulla of 2 m mice showed 19% of cells positively labeled for huntingtin with diffuse nuclear immunoreactivity without inclusions, and a 2.91% of cells with nuclear inclusions (Fig. 3c) , smaller than those presented by 7 m mice.
Cell excitability
Resting membrane potential (V m ), spontaneous action potentials (sAPs), acetylcholine (ACh)-evoked cell depolarization and ACh-evoked APs (eAPs) were explored in currentclamped mouse chromaffin cells (MCCs) from WT and R6/1 at 2 m and 7 m of age. At 7 m, drastic differences between WT and R6/1 MCCs were observed. For instance, traces of panel B (Fig. 4) show a near silent R6/1 cell (b2), in comparison with the WT cell (b1) that discharges various bursts of sAPs. This fits well with the observation that V m was more hyperpolarized in R6/1 cells, in comparison with WT cells (b3). It seems plausible that if cells have a more hyperpolarized V m , the threshold to discharge APs will be higher, and lesser number of those APs will be produced. This is consistent with the drastic reduction of sAPs in R6/1 cells (about 2 sAPs) with respect WT cells (15 sAPs). Furthermore, in spite of the fact that 100 lM ACh produced similar cell depolarizations (panels d1,d2,d3) the number of eAPs was reduced from 26 in WT cells to 8 in R6/1 cells (panel d4).
We also analyzed the kinetic parameters of single sAPs and eAPs; data are summarized in Table 1 (for sAPs) and Table 2 (for eAPs). Consistent with the lack of differences in the resting V m and AP numbers (Fig. 4a and c) , also there was no differences in the kinetic parameters between WT and R6/1 cells at 2 m of age (Fig. 4e,e1) . However, the kinetics of those APs considerably differed between 7 m WT and R6/1 cells. Thus, with respect WT cells, the R6/1 cells had the following significant changes: slower rising and decay slopes, smaller areas, and smaller after hyperpolarization (AHP). The modeled averaged APs as a function of those parameters are displayed in Fig. 4e . While APs overlapped in 2 m cells, APs at 7 m clearly differed: the AP of R6/1 cells have smaller amplitude and smaller AHP (Fig. 4e,e2,e3 , expanded AHP).
Ion currents
Whether altered excitability in R6/1 MCCs was linked to modified ion currents, was explored in cells voltage-clamped at À80 mV. Cell size was monitored with phase contrast microscopy and membrane capacitance. At 2 m, WT and R6/ 1 cells exhibited similar sizes both, through microscopy visual inspection (Fig. 5, Aa1 ) and through membrane capacitance monitoring that was 7.4 pF 59 WT cells and The whole-cell inward sodium current (I Na ) was recorded with solutions of the following composition (in mM): 100 Csglutamate, 14 EGTA, 20 TEA-Cl, 10 NaCl, 5 Mg-ATP, 0.3 Na-GTP, and 20 HEPES (pH 7.3, CsOH) and the external solution contained 0 nominal Ca 2+ . I Na was generated by 10 ms depolarizing steps (from -60 mV to +60 mV) in cells voltage-clamped at -80 mV. Example current traces are presented in Fig. 5b, b1 and b3 . At 2 m, R6/1 I Na current was larger than the WT current (b1) while at 7 m, I Na was considerably smaller in R6/1, with respect WT cells (b3). These contrasting data are better illustrated with the I-V curves for I Na at 2 m (b2) and 7 m (b4): peak current at 2 m was -190.8 AE 20.7 pA/pF in 25 WT cells and -266.7 AE 24.3 pA/pF in 24 R6/1 cells. Thus, at 2 m R6/1 mice present 39.8% more I Na current than WT mice; on the contrary, at 7 m peak I Na was -195.1 AE 16.66 pA/pF in 23 WT cells and -114.8 AE 15.35 pA/pF in R6/1 cells, which means a 41.2% I Na decrease in R6/1 cells in comparison with WT cells. This decrease was not because of the fact CCs had a smaller size and hence surface area in 7 m R6/1 cells with respect WT cells (Fig. 5a) , because the absolute values of peak currents were normalized in terms of cell capacitance, and expressed as pA/pF. This was also done in the case of the rest of the currents described next.
The inward current through the nicotinic receptor ion channel was triggered by 250 ms pulses of ACh at 100 lM. Current traces and pooled data on peak currents showed no differences between WT and R6/1 MCCs at 2 m and 7 m (Fig. 6a,a1,a2) . Neither, the inward currents through voltageactivated calcium channel triggered by depolarizing voltagesteps, exhibited significant differences between the four cell types (panel B, b1, and b2). This was also the case for the outward calcium-dependent component of the whole-cell potassium current (I K(Ca) ; panels C, c1, and c2 of Fig. 6 indicates the similarity of the current traces and the I-V curves in 2 m and 7 m WT and R6/1 cells. Finally, the voltagedependent component of outward potassium currents (I K(V) ) was also similar in the four cell types (panels D, d1,d2).
Cytosolic calcium transients
The changes in [Ca 2+ ] c elicited by stimulation with ACh (100 lM for 1 min) or high K + (70 mM for 1 min) were studied in MCCs loaded with fura-2, at the single-cell level. with K + (Fig. 7f) . With respect the AUC (area of the [Ca 2+ ] c transient), it was about 30-40% smaller in K + stimulated R6/ 1 cells, either at 2 m and 7 m (Fig. 7e) .
Quantal catecholamine release triggered by acetylcholine or high potassium in chromaffin cells from WT and R6/1 mice Experiments were performed in CCs kept in culture for 1 day. The single cell being explored was continuously being perifused with a Tyrode solution containing 2 mM Ca 2+ at 37°C. After the carbon fiber microelectrode was in place smoothly touching the cell surface, a 1-min initial resting period was allowed to reach a stable baseline amperometric recording. During this period cells were usually silent; cells having spontaneous secretory events were discarded. This was necessary for the sake of clarity when analyzing the secretory responses triggered by the 1-min application of ACh (100 lM) or high K + (70 mM, abbreviated as K + ). A given cell from a culture dish was stimulated with ACh or K + only once. About 70% of the cells tested responded to those stimuli.
Typical secretory responses in WT cells at 2 m age challenged with ACh (Fig. 8a) or K + (Fig. 8b) consisted in an initial spike burst that was followed by lower frequency spikes; then, cells were silent in spite of the fact the stimulus continued. This pattern of secretion is better illustrated upon the plotting of cumulative spike number (SN) counted at 5-s intervals in each individual trace; a fast initial rising phase (corresponding to the initial spike burst) was followed by a much slower rising phase close to a plateau. The SN versus time curves were similar in WT and R6/1 cells from 2 m mice (Fig. 8c) . Surprisingly, when cumulative secretion was calculated (at 5-s intervals) as spike areas (an index of total quantal secretion of catecholamine, Q amp in pC), this was approximately halved in R6/1 cells, with respect WT cells from 2 m mice (Fig. 8d) . A similar picture emerged from 2 m cells stimulated with K + : while cumulative SN versus time curves were similar in WT and R6/1 cells (Fig. 8e) , total secretion was reduced by 31% in R6/1 cells with respect WT cells (Fig. 8f) . WT (2 m) 43.0 AE 4.6 5.4 AE 0.8 7.8 AE 1.7 4.6 AE1.0 À10.7 AE 2.4 229 AE 27 5.5 AE 0.9 À8.7 AE 1.1 À138 AE 28 R6/1 (2 m) 41.9 AE 4.3 6.4 AE 0.5 5.1 AE 0.7 5.6 AE 0.7 À8.1 AE 1.2 260 AE 16 6.3 AE 0.9 À7.2 AE 1.2 À97 AE 26 WT (7 m Data are presented as means AE SEM with relative change in R6/1 respect to WT. *p < 0.05, **p < 0.001, ***p < 0.0001 in R6/1 with respect to WT chromaffin cells for each stimulus and age (Mann-Whitney test).
In 7 m cells stimulated with ACh, the SN was reduced by 30% in R6/1 with respect WT mice (Fig. 8g) . Cumulative secretion was notably reduced (by over 65%) in R6/1 cells compared with WT cells. Finally, in K + stimulated cells the secretory responses monitored as SN were similar in both cells types (Fig. 8i) and once more, when calculated as cumulative total secretion, the response was depressed by 43% in R6/1 cells with respect WT cells (Fig. 6j) .
Kinetics of single exocytotic events
Analysis of the exocytotic amperometric events was done on individual spikes of all secretory traces described in Fig. 8 , obtained from the four cell types here studied namely, WT at 2m and 7 m and R6/1 at 2 m and 7 m. The parameters monitored are illustrated in the example spike of Fig. 9a ; they are collected in Tables 3 and 4.  Table 3 summarizes the values of foot parameters. The number of single events validated and analyzed ranged from Foot duration (T foot ) as well as quantal size (Q foot ) were also reduced in R6/1, with respect WT cells. As the foot preceding a full spike indicates the initial formation of the fusion pore of the exocytotic event (Chow et al. 1992) , it seems that the fusion pore is formed faster and gives rise more promptly to its full expansion in R6/1 cells, with respect WT cells challenged either with ACh or K + . As far as the kinetic analysis of the full spike is concerned, we found the following differences. Rise rate was slower in R6/1 cells stimulated with ACh at 2 and 7 m. In contrast, spike amplitude (I max ) was significantly smaller in R6/1 with respect WT, both at 2 m and 7 m and with the two stimuli used, ACh and K + ( Table 4) . The next parameter, the decay rate was faster in R6/1 cells in all conditions, suggesting a faster fusion pore closure, in comparison with WT cells. In agreement with those previous differences, the halftime (t 1/2 ) of the spike had shorter duration, indicating a narrower spike in R6/1 with respect WT cells. Finally the quantal size, an indication of the catecholamine content per vesicle, was also diminished (by 40-50%) in R6/1 cells.
Summing up, from all parameters here analyzed it can be concluded that the averaged, modeled single exocytotic event from R6/1 CCs have a fusion pore faster, that promptly undergoes its expansion to release the vesicle catecholamine content in a more rapid and transitory mode, in comparison with WT cells. These changes are present at both early presymptomatic disease stages (2 m) ( Fig. 9b and c) and at disease stages (7 m) ( Fig. 9d and e) , with stimulation either with ACh or K + .
Discussion
We found here deep alterations in cell excitability, ion currents, and exocytosis in CCs of the R6/1 mouse model of HD, with respect their WT littermates. A striking finding was an augmented I Na in 2 m CCs and a drastic diminution in 7 m CCs (Fig. 5b ). This fits with the drastic decrease in the number of sAPs and eAPs in 7 m CCs (Fig. 4) indicating a considerable lesser excitability with augmented V m , in comparison with WT 7 m R6/1 CCs. Of interest were data showing that I Ca , I K(Ca) , and I K(V) were unaffected, meaning that altered Na + channels of 7 m R6/1 CCs were selectively damaged. This keeps pace with the observation that downregulation of the b4 regulatory subunit of the Na + channel alters its function in a mouse model of HD as well as in patients, leading to neurodegeneration (Oyama et al. 2006) .
The decreased I Na may also be because of the expression of this channelopathy in CCs; this could explain the smaller size of catecholamine-storing vesicles with decreased DBH levels, catecholamine contents, and cell size shown in 7 m adrenal medullary tissue (Fig. 2) and CCs (Fig. 5a ). Giving the fact CCs are sympathetic-like neurons, we may conclude that as CNS neurons, these peripheral cells are also undergoing a 'neurodegenerative-like' process associated to the over-expression of aggregated mutated huntingtin (Fig. 3d) .
Lesser SN release from ACh stimulated CCs indicated that a lesser number of catecholamine-storing vesicles are undergoing exocytosis in CCs from 7 m WT cells (Fig. 8g) . As DBH (a marker of secretory vesicles) and DA, NA, and AD are markedly decreased in 7 m cells (Fig. 2) , this may explain the decreased SN released per ACh stimulus. An alternative possibility to explain such release decline is a lesser Ca 2+ availability to the secretory machinery. However, similar I Ca (Fig. 6b) and [Ca 2+ ] c transients ( Fig. 7) suggest that decreased Ca 2+ availability cannot explain the decreased vesicle number undergoing exocytosis in 7m CCs challenged with the physiological stimulant ACh.
An interesting point concerns the quantal size namely, the amount of catecholamine content of a single vesicle, reflected by the area of a single exocytotic amperometric event (Wightman et al. 1991; Chow et al. 1992; Machado et al. 2008) . Inasmuch as cumulative secretion (Qamp in pC) was markedly reduced in R6/1 CCs both at 2 m and 7 m ages, yet spike number were unaffected (except for 7 m R6/1 cells stimulated with ACh) (Fig. 8d ,f,h,j), this can be best explained by a reduction in quantal size. This was clearly corroborated with the analysis of the single-spike kinetics: Q was significantly and markedly reduced in R6/1 CCs at 2 m and 7 m, with respect WT cells of matched ages (Table 4) . The rest of the kinetic parameters were also altered. When modeled, they showed prototype spikes with a fusion pore (foot) that stabilized faster, giving rise also to a slower expansion and faster closure, in R6/1 cells with respect WT cells. The faster release of catecholamines per vesicle could also be associated to its lower quantal size: lesser catecholamines will last shorter in being release to the extracellular space. Thus, faster emptying of diminished vesicle content could be an alternate or complementary explanation of our kinetic data.
Of interest was the fact some parameters appeared altered at a pre-disease stage, and were further altered at a disease stage in R6/1 mice. They were as follows; (i) diffuse mutated huntingtin was already expressed at 2 m in some cells and as aggregates in many more cells at 7 m; (ii) catecholamine tissue content was depressed at 2 m and further depressed at 7 m; (iii) cumulative total secretion (quantal content) was decreased at 2 m and further decreased at 7 m; (iv) catecholamine content per vesicle (quantal size) was diminished at 2 m and further diminished at 7 m. Other parameters were altered only at 7 m; this was the case of impaired motor function. And still other parameters exhibited opposite behavior with disease progression; this was the case of the Na + current that as commented above, was augmented at 2 m and deeply depressed at 7 m. This led to pronounced depression of cell excitability but only at 7 m. And still other parameters were similarly altered, as the case was for the stabilization, expansion, and closure of the fusion pore that led to inefficient or partial secretory responses both at 2 m and 7 m in R6/1 CCs (Fig. 9) . The fact so many functional parameters were already altered at 2 m suggests they are prone to serve as peripheral markers for early disease diagnosis. At pre-symptomatic stages, the carriers of HD mutated gene could be more vulnerable to their reaction to stress as suggested by the poorer and altered catecholamine secretory responses here found at pre-disease stages in R6/1 mice carrying the human disease mutation with around 115 CAG repeats (Mangiarini et al. 1996) . Thus, the monitoring of responses to stimulation of the sympatho-adrenal axis in for instance family carriers of mutated huntingtin (Vonsattel and DiFiglia 1998) could serve as a marker for early diagnosis of HD.
Our study adds to a growing literature on the alterations of exocytosis in either CCs from transgenic mice carrying a mutation of a neurodegenerative disease, or in MCCs expressing a protein linked to those diseases. We previously explored the kinetics of the exocytotic fusion pore in MCCs stimulated with K + from the aged APP/PS1 mouse model of AD; we found that spike secretory events were faster and had a smaller quantal size, with respect their age matched control counterparts. However, although Ab plaques were present in the brains of APP/PS1 mice, Ab pathology was not found in MCCs, indicating that altered exocytosis occurred through a mechanism not directly linked to established Ab pathogenesis of AD (de Diego et al. 2012) . Furthermore, CCs stimulated with ACh of the SOD1 G93A mouse model of amyotrophic lateral sclerosis, exhibited a exocytotic spike event that was slower but with a higher quantal size, in P120 mice with established motor disease; this was accompanied by diminution of CC excitability and augmented Ca 2+ currents (Calvo-Gallardo et al. 2015) . In a third earlier study both, depressed dopamine release from the striatum and catecholamine release from CCs were reported to occur in the R6/2 mouse model of HD, at age of 3 months when the phenotypic motor disease was already established. In this study, decrease vesicle quantal size was also reported, a fact that authors attributed to a dysfunction of the vesicle monoamine transporter (Johnson et al. 2007) . It is interesting the fact CCs from R6/1 (this study) and a previous study on R6/2 mice (Johnson et al. 2007 ) exhibit similar decrease in catecholamine release and single-vesicle quantal size; this indicates similar alterations of the exocytotic fusion pore in the juvenile model of disease onset (R6/2) with 150 CAG repeats and the model of delayed disease onset (R6/1 with 115 CAG repeats) (Mangiarini et al. 1996) . As done here with the R6/1 mouse, it would be interesting to explore whether the R6/2 model of rapid disease onset also exhibits expression of huntingtin in its CCs, as well as the decrease in Na + current and cell excitability. Additionally, the huntingtin-associated protein 1 (HAP1) is known to be localized to synaptic vesicles (Li et al. 2000) and to CC vesicles (Dragatsis et al. 2000; Liao et al. 2005) . Furthermore, HAP1 has been implicated in the regulation of vesicle docking and stabilization of the exocytotic fusion pore (Mackenzie et al. 2014) as well as in the regulation of endocytosis through its interaction with clathrin in MCCs (Mackenzie et al. 2017) . It could be very interesting to explore the role of HAP1 in CCs from R6/1 as well as R6/2 mouse models of HD, on the exocytotic fusion pore. This could clarify to what extent the altered cell excitability and exocytotic parameters here reported for R6/1 MCCs are because of the mutated huntingtin and its interaction with HAP1.
In the brain, the expression of mutated huntingtin has been associated to synaptic dysfunctions (Li et al. 2003) and to diminished exocytotic release of dopamine (Johnson et al. 2006 (Johnson et al. , 2007 , ACh (Vetter et al. 2003) , and glutamate (Li et al. 2003) . As mutated huntingtin is also over-expressed in peripheral adrenal medullary CCs, it seems reasonable to conclude that the brain pathogenic features of HD leading to altered neurotransmission also occurs in peripheral CCs, leading to altered exocytosis. In this context, an interesting question concerns the possible over-expression of mutated huntingtin in the adrenal medullary chromaffin cells of HD patients.
In conclusion, we here found that several pathogenic brain features of HD also occur in adrenal medullary CCs of R6/1 a mouse model of HD. These alterations are mainly as follows: (i) over-expression of huntingtin aggregates; (ii) decreased cell excitability with lesser action potentials associated to cell hyperpolarization and decreased sodium current; (iii) decreased CC size, catecholamine contents and DBH expression; (iv) faster kinetics of exocytotic fusion pore formation and stabilization, slower expansion, and faster closure; and (v) decreased single-vesicle quantal size. On the basis of these changes we here raise the hypothesis that nuclear deposition of mutated huntingtin at disease stages, could primarily be responsible for poorer Na + channel expression and function, with ensuing deep depression of cell excitability, altered Ca 2+ handling, and exocytosis in CCs of R6/1 mouse model of HD. These pathological features could result in poorer adaptation to stressful conflicts, as disease progresses in HD patients. In addition, the use of easy access adrenal CCs with powerful electrophysiological, amperometric, and microfluoresce techniques could further enlighten some novel pathogenic features of HD. Finally, as several of those changes occur at pre-disease stages, their monitoring could be used as markers for early disease diagnosis. Results in each investigation suggest HD is not only a disease of the CNS. The sympatho-adrenal axis, which is tightly controlled by cortical neurons via hypothalamus, brain-stem, and spinal cord, seems to be deeply altered, suggesting poorer responses to stress of HD patients.
